The Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) was established by the Department of Medicine in 2019 to support both fundamental and translational research on human disease.
The aim of our new graduate programme is to improve our knowledge and understanding of the pathogenesis of immune and infectious disorders, and develop therapeutic strategies to benefit human health. No single student can be experienced in all these areas, but by providing rigorous training in our newly opened, well-resourced scientific institute, this programme aims to equip the next generation of scientists with the necessary skills and broad academic insight to bring novel and innovative approaches to the study of immunity and infection.
CITIID focuses on immunity and infection research and is embedded in the Biomedical campus in Cambridge. Our graduate students will have access to advanced facilities which will enable them to optimise their work on both basic and clinical aspects of immune and infectious disorders. CITIID brings together a unique partnership of strength in basic research and clinical capabilities. It is therefore well-placed to drive therapeutic breakthroughs, improve patient outcomes and advance health.